Free Trial

Shuttle Pharmaceuticals (SHPH) Competitors

Shuttle Pharmaceuticals logo
$0.13 -0.01 (-9.35%)
Closing price 04:00 PM Eastern
Extended Trading
$0.13 0.00 (-1.36%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SHPH vs. APLM, GTBP, MYNZ, SBFM, CHRO, OMGA, IMCC, KTTA, ALBT, and AIM

Should you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include Apollomics (APLM), GT Biopharma (GTBP), Mainz Biomed (MYNZ), Sunshine Biopharma (SBFM), Chromocell Therapeutics (CHRO), Omega Therapeutics (OMGA), IM Cannabis (IMCC), Pasithea Therapeutics (KTTA), Avalon GloboCare (ALBT), and AIM ImmunoTech (AIM). These companies are all part of the "pharmaceutical products" industry.

Shuttle Pharmaceuticals vs. Its Competitors

Shuttle Pharmaceuticals (NASDAQ:SHPH) and Apollomics (NASDAQ:APLM) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation.

Shuttle Pharmaceuticals has higher earnings, but lower revenue than Apollomics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shuttle PharmaceuticalsN/AN/A-$6.59M-$4.15-0.03
Apollomics$1.22M5.82-$172.60MN/AN/A

In the previous week, Shuttle Pharmaceuticals had 6 more articles in the media than Apollomics. MarketBeat recorded 7 mentions for Shuttle Pharmaceuticals and 1 mentions for Apollomics. Apollomics' average media sentiment score of 1.87 beat Shuttle Pharmaceuticals' score of 0.48 indicating that Apollomics is being referred to more favorably in the news media.

Company Overall Sentiment
Shuttle Pharmaceuticals Neutral
Apollomics Very Positive

Apollomics' return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Shuttle PharmaceuticalsN/A -583.02% -258.92%
Apollomics N/A N/A N/A

Apollomics received 4 more outperform votes than Shuttle Pharmaceuticals when rated by MarketBeat users.

CompanyUnderperformOutperform
Shuttle PharmaceuticalsN/AN/A
ApollomicsOutperform Votes
4
80.00%
Underperform Votes
1
20.00%

4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. Comparatively, 19.1% of Apollomics shares are owned by institutional investors. 12.6% of Shuttle Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Shuttle Pharmaceuticals has a beta of -1.1, suggesting that its stock price is 210% less volatile than the S&P 500. Comparatively, Apollomics has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500.

Summary

Apollomics beats Shuttle Pharmaceuticals on 7 of the 10 factors compared between the two stocks.

Get Shuttle Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SHPH vs. The Competition

MetricShuttle PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1.46M$6.85B$5.56B$8.50B
Dividend YieldN/A2.53%5.28%4.16%
P/E Ratio-0.038.4326.6419.64
Price / SalesN/A262.52407.99152.17
Price / CashN/A65.8538.2534.64
Price / Book0.076.536.974.60
Net Income-$6.59M$143.25M$3.23B$248.06M
7 Day Performance-27.59%0.21%-0.98%-1.03%
1 Month Performance-36.18%10.92%7.70%3.50%
1 Year PerformanceN/A2.44%31.32%12.68%

Shuttle Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SHPH
Shuttle Pharmaceuticals
0.8016 of 5 stars
$0.13
-9.4%
N/AN/A$1.46MN/A-0.035News Coverage
Stock Split
Short Interest ↓
High Trading Volume
APLM
Apollomics
1.2414 of 5 stars
$6.55
flat
N/A-68.7%$7.23M$1.22M0.0045Gap Down
GTBP
GT Biopharma
2.6733 of 5 stars
$2.79
+3.0%
$11.00
+294.3%
-5.4%$7.22MN/A-0.498Positive News
Short Interest ↑
Gap Up
MYNZ
Mainz Biomed
2.7735 of 5 stars
$2.05
+0.2%
$14.00
+584.6%
-92.5%$7.02M$893.99K-0.0330Positive News
Gap Down
SBFM
Sunshine Biopharma
2.8579 of 5 stars
$1.52
+7.2%
$15.00
+885.5%
+457.5%$6.95M$36.23M-0.013
CHRO
Chromocell Therapeutics
1.1778 of 5 stars
$1.05
+2.9%
N/A+3.9%$6.93MN/A-0.854Short Interest ↓
Gap Up
OMGA
Omega Therapeutics
1.9676 of 5 stars
$0.13
-21.8%
$9.20
+7,260.0%
-94.1%$6.92M$8.10M-0.09120Upcoming Earnings
Gap Up
IMCC
IM Cannabis
0.4083 of 5 stars
$3.05
-12.4%
N/A-8.4%$6.81M$54.47M-0.89340Short Interest ↑
Gap Down
High Trading Volume
KTTA
Pasithea Therapeutics
1.5848 of 5 stars
$0.91
-2.5%
N/A-85.7%$6.75MN/A-0.093Short Interest ↓
Gap Down
ALBT
Avalon GloboCare
2.2102 of 5 stars
$3.55
-2.5%
N/A-59.0%$6.72M$1.37M-0.185Short Interest ↓
AIM
AIM ImmunoTech
2.0323 of 5 stars
$0.09
-22.3%
$2.75
+2,908.8%
-76.1%$6.61M$170K-0.1920News Coverage
Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:SHPH) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners